Skip to main content | / Skip to navigation | ... We have an active portfolio including biomarkers studies, immunotherapy, phase I/II
clinical trials, phase III trials, radiotherapy, late effects and disease prevention. ...
http://www.medicine.manchester.ac.uk/cancerstudies/